Literature DB >> 17071712

Metastatic non-small-cell lung carcinoma successfully treated with pre-operative chemotherapy and bilateral adrenalectomy.

Alberto Muñoz1, Guillermo López-Vivanco, Joan-Manel Mañé, Ricardo Fernández, Javier Díaz-Aguirregoitia, Mónica Saiz, Ramón Barceló.   

Abstract

Metastatic non-small-cell lung cancer is a common condition with a dismal prognosis. Although palliative chemotherapy improves survival and quality of life, nearly all patients die of progressive disease. Metastatic involvement of adrenal glands is not rare, but usually reflects widespread dissemination. Selected patients with single adrenal metastasis may be cured with surgery, although the level of evidence comes from single cases reports and short retrospective series. Here we report a patient with bilateral adrenal metastases from previously resected non-small-cell lung cancer, who remains free of disease four years after pre-operative chemotherapy and bilateral adrenalectomy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071712     DOI: 10.1093/jjco/hyl101

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  3 in total

1.  Symptomatic large bilateral adrenal metastases at presentation in small-cell lung cancer: a case report and review of the literature.

Authors:  Navneet Singh; Karan Madan; Ashutosh N Aggarwal; Ashim Das
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Oligometastatic non-small cell lung cancer (NSCLC): adrenal metastases. Experience in a single institution.

Authors:  Mirko Barone; Decio Di Nuzzo; Giuseppe Cipollone; Pierpaolo Camplese; Felice Mucilli
Journal:  Updates Surg       Date:  2015-11-20

3.  Long-term survival after surgical treatment of metachronous bilateral adrenal metastases of non-small cell lung carcinoma.

Authors:  Naohiro Taira; Tsutomu Kawabata; Takaharu Ichi; Kazuaki Kushi; Tomofumi Yohena; Hidenori Kawasaki; Kiyoshi Ishikawa
Journal:  Am J Case Rep       Date:  2014-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.